M N Blackburn

Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma

T K Hart, M N Blackburn, Michael Brigham‐Burke et al. · Clinical & Experimental Immunology · 2002 · 200 citations · Full text

Asthma, Clinical Immunology, Inflammatory Lung Disease +19

Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding.

Cynthia B. Peterson, M N Blackburn · Journal of Biological Chemistry · 1985 · 143 citations · Full text

The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.

M N Blackburn, Robert L. Smith, John H. Carson et al. · Journal of Biological Chemistry · 1984 · 99 citations · Full text

Protein Chemistry, Critical Tryptophan, Protein Function +15

Identification of a lysyl residue in antithrombin which is essential for heparin binding.

Cynthia B. Peterson, Claudia M. Noyes, J M Pecon et al. · Journal of Biological Chemistry · 1987 · 77 citations · Full text

Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.

ME Nesheim, M N Blackburn, Casey Lawler et al. · Journal of Biological Chemistry · 1986 · 67 citations · Full text